Apoptosis induced by activation of peroxisome-proliferator activated receptor-gamma is associated with Bcl-2 and Nf-kB in human colon cancer

被引:131
作者
Chen, GG [1 ]
Lee, JFY
Wang, SH
Chan, UPF
Ip, PC
Lau, WY
机构
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Shatin, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Prince Wales Hosp, Sir YK Pao Ctr Canc, Shatin, Hong Kong, Peoples R China
[3] Univ Michigan Med, Sch Med, Dept Internal Med, Ann Arbor, MI USA
关键词
colon cancer; peroxisome-proliferator activated receptor-gamma; apoptosis;
D O I
10.1016/S0024-3205(02)01510-2
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Peroxisome-proliferator activated receptor-gamma (PPAR-gamma) has been demonstrated to exert an inhibitory effect on cell growth in most cell types studied, but its role in colon cancer is still uncertain. The molecular mechanism between the activation of PPARgamma and its consequence is unknown. In the present report, we show that the expression of PPARgamma was significantly increased in tumor tissues from human colon cancer compared with non-tumor tissues and that PPARgamma ligands, 15-Deoxy-Delta(12,14)- prostaglandin J(2) or ciglitizone, induced apoptosis in HT-29 cells, a human colon cancer cell line. The occurrence of apoptosis induced by PPARgamma ligands was sequentially accompanied by reduced levels of NF-kB and Bcl-2. Over-expression of Bcl-2 significantly protected the cells from apoptosis. This study suggested that a PPARgamma-Bcl-2 feedback loop may function to control the life-death continuum in colonic cells and that a deficiency in generation of PPARgamma ligands may precede the development of human colon cancer. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:2631 / 2646
页数:16
相关论文
共 31 条
  • [21] Differentiation and reversal of malignant changes in colon cancer through PPARγ
    Sarraf, P
    Mueller, E
    Jones, D
    King, FJ
    DeAngelo, DJ
    Partridge, JB
    Holden, SA
    Chen, LB
    Singer, S
    Fletcher, C
    Spiegelman, BM
    [J]. NATURE MEDICINE, 1998, 4 (09) : 1046 - 1052
  • [22] Loss-of-function mutations in PPARγ associated with human colon cancer
    Sarraf, P
    Mueller, E
    Smith, WM
    Wright, HM
    Kum, JB
    Aaltonen, LA
    de la Chapelle, A
    Spiegelman, BM
    Eng, C
    [J]. MOLECULAR CELL, 1999, 3 (06) : 799 - 804
  • [23] PPARγ and colorectal carcinoma:: Conflicts in a nuclear family
    Seed, B
    [J]. NATURE MEDICINE, 1998, 4 (09) : 1004 - 1005
  • [24] Sheng HM, 1998, CANCER RES, V58, P362
  • [25] A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response
    Su, CG
    Wen, XM
    Bailey, ST
    Jiang, W
    Rangwala, SM
    Keilbaugh, SA
    Flanigan, A
    Murthy, S
    Lazar, MA
    Wu, GD
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (04) : 383 - 389
  • [26] A pathway of neuronal apoptosis induced by hypoxia/reoxygenation:: Roles of nuclear factor-κB and Bcl-2
    Tamatani, M
    Mitsuda, N
    Matsuzaki, H
    Okado, H
    Miyake, S
    Vitek, MP
    Yamaguchi, A
    Tohyama, M
    [J]. JOURNAL OF NEUROCHEMISTRY, 2000, 75 (02) : 683 - 693
  • [27] Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFκB activation in primary hippocampal neurons
    Tamatani, M
    Che, YH
    Matsuzaki, H
    Ogawa, S
    Okado, H
    Miyake, S
    Mizuno, T
    Tohyama, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (13) : 8531 - 8538
  • [28] Thompson MA, 1998, CANCER RES, V58, P5168
  • [29] A nuclear receptor to prevent colon cancer.
    Wu, GD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (09) : 651 - 653
  • [30] Yang HB, 1999, ANTICANCER RES, V19, P727